NPI: 1235457508 · GLENDALE, WI 53209 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/12/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/12/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 42,127 | $852K |
| 2019 | 46,783 | $730K |
| 2020 | 41,502 | $603K |
| 2021 | 34,211 | $607K |
| 2022 | 31,769 | $470K |
| 2023 | 14,811 | $450K |
| 2024 | 12,530 | $340K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 86,333 | 6,220 | $3.96M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 62,116 | 2,852 | $48K |
| A4657 | Syringe, with or without needle, each | 5,026 | 3,604 | $24K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 933 | 366 | $10K |
| J1756 | Injection, iron sucrose, 1 mg | 17,842 | 3,291 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 35,522 | 2,507 | $2K |
| 90747 | 62 | 60 | $613.65 | |
| 90674 | 160 | 121 | $32.28 | |
| 83540 | 1,403 | 1,131 | $0.00 | |
| 85041 | 3,023 | 2,355 | $0.00 | |
| 85048 | 2,991 | 2,323 | $0.00 | |
| 83970 | 2,503 | 1,983 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,126 | 515 | $0.00 |
| 90662 | 65 | 60 | $0.00 | |
| 84466 | 14 | 12 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 477 | 376 | $0.00 |
| 83550 | 1,184 | 944 | $0.00 | |
| 82728 | 1,417 | 1,135 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,064 | 734 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 214 | 182 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 41 | 40 | $0.00 |
| 82746 | 99 | 87 | $0.00 | |
| 82607 | 101 | 90 | $0.00 | |
| 87340 | 17 | 15 | $0.00 |